Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERO
NCT05682859Phase 4Completed
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in chronic hand eczema (CHE). Started Sep 2023; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT05682859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05682859.